Haloperidol Lactate

   
Google
 
Web NewDrugInformation.com

Haloperidol Lactate


Drug - Haloperidol Lactate
The trade name of the product as shown on the labeling.

Dosage - SOLUTION; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Haloperidol Lactate
Multiple ingredients are in alphabetical order.

Strength - EQ 1MG BASE/ML
The potency of the active ingredient(s), Haloperidol Lactate. May repeat for multiple part products.

Applicant - UDL
The firm name holding legal responsibility for Haloperidol Lactate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 074536
The FDA assigned number to Haloperidol Lactate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Haloperidol Lactate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 2, 1995
The date Haloperidol Lactate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Haloperidol Lactate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Haloperidol Lactate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Udl Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Haloperidol Lactate.

Haloperidol Lactate